Filter By
- Agency-Based Community Benefit (ABCB)
- Behavioral Health Reform and Investment Act Senate Bill 3 (SB3)
- (-) Beneficiary Advisory Council (BAC)
- Child Support Services
- DDSD Provider Enrollment & Relations
- Electronic Benefits Transfer (EBT)
- Employee Abuse Registry (EAR)
- Fraud, Waste, & Abuse
- (-) Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- (-) Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- Marketplace Affordability Programs
- Medicaid Transition Premium Relief Program
- National Guard Premium Assistance
- New Mexico Medicaid Estate Recovery Program
- Ordering, Referring, Prescribing Provider (ORP)
- Refugee Resettlement Program
- Rural Health Care Delivery Fund
- Small Business Health Insurance Premium Relief Initiative
- SNAP Quality Control Reviews
- State Employee Premium Assistance Program
- Sun Bucks
- Supplemental Nutrition Assistance Program (SNAP)
- Turquoise Care
The BAC will meet quarterly, online using Microsoft Teams. Attendees will be able to log on by using telephone or internet.
Members must be willing to serve on the BAC for two years. Regular attendance and participation is expected of all members. If more than two meetings in a row are missed, the BAC member may be replaced.
Approximately 2-3 hours each quarter.
15 members will be selected.
We want the BAC to reflect the diversity of New Mexico’s members, including:
- People from various racial and ethnic backgrounds found in New Mexico,
- English language learners,
- Parents of young children,
- Young adults,
- People with disabilities,
- Individuals who use behavioral health services,
- Residents from urban, rural, and frontier areas of New Mexico,
- Members from New Mexico’s Tribes, Pueblos, and Nations, and
- Dual eligibility members (who are enrolled in Medicaid and Medicare)
Applications are currently closed for the BAC and will reopen every year to welcome new members.
Applications will be reviewed, and members will be notified June 30, 2025.
All licensed hospitals and certain health care provider organizations (as defined in the legislation) proposing a merger, acquisition, or change in majority ownership/control must submit a Transaction Notice to DHI before closing.
The Health Care Consolidation Act applies to any “transaction,” defined as:
1. A merger of one hospital into another;
2. An acquisition of a hospital by another entity; or
3. A change of control of hospital ownership or real estate.
You’ll have 30 days from the initial filing to respond to any requests for missing information. A submission becomes “complete” once HCA has received all required documents, exhibits, and fees.
You can still submit written comments through the end of the comment period. All submissions—oral or written—are given equal weight in HCA’s review.
The Health Care Consolidation Oversight Act authorizes HCA to retain specialized consultants—such as actuaries, financial analysts, or legal experts—to assist with complex transaction reviews. The hospital (or transaction parties) is responsible for reimbursing the HCA’s actual costs for these services.
If HCA denies or conditions your transaction, you may request a contested-case hearing under the Uniform Licensing Act (U.L.A.) within 30 days of the decision notice.
Yes. All documents you file with HCA are treated as confidential under the Health Care Consolidation Oversight Act. If you believe certain exhibits should remain proprietary, clearly mark them “CONFIDENTIAL” and file a redacted public version.
Once your submission is complete, HCA has 120 days to issue a decision. Complex transactions or those flagged as “urgent” may follow an accelerated schedule at HCA’s discretion.
For three years following your transaction, you’ll submit yearly updates on financial performance, service volumes, community benefit activities, and any material changes—using the format HCA provides. You can fill out and submit the report form HERE. You will also need to include THIS FORM in your submission.
You can fill out the annual report form HERE. You will also need to fill out and inlcude THIS FORM in the submission.
Under the Health Care Consolidation Oversight Act, HCA may impose administrative fines on hospitals or transaction parties that knowingly violate filing requirements, proceed with a transaction without approval, or fail to comply with conditions. Fines are assessed on a per‑bed or per‑member basis (as specified in the administrative rules) and revenues are directed to the New Mexico School Fund.
You can find a full list of definitions of terms contained in the act HERE.
Yes. The Health Care Consolidation Oversight Act includes safeguards for individuals who report improper or undisclosed transactions. Whistleblowers may submit information confidentially to the HCA and are protected from retaliation. Any fine revenue collected from violations stemming from a whistleblower report also supports the School Fund.
Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.
Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.
Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.
No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.
No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.
Yes. pharmacy providers are required to submit claims through the point-of-sale system. The point-of-sale system provides relevant drug utilization information that the pharmacist must consider before dispensing a drug. Pharmacies must follow the NM FFS Payer Sheet. The BIN for JUST Health Plus members is 028165, and pharmacy software systems must be updated accordingly so that patient profiles can reflect the new BIN. Additionally, pharmacies must have POS equipment capable of billing D.0 transactions to ensure claims can be received, processed, and sent for payment in the Turquoise Care System.
Yes. Carceral facilities with 340B-acquired medications must identify 340B participation and pricing on claims by using modifiers “UD” or “08” when billing Medicaid for the applicable medications. Please refer to Provider Supplement 20-04 for further instructions on billing for 340B-acquired medications.
HCA expects the ordering provider to determine clinical appropriateness of a new prescription. Providers have the option of overriding a “Fill too Soon” rejection. If utilization information indicates that the member has an adequate supply of the medication or that the quantity being dispensed is excessive, the pharmacist is responsible for resolving the issue by seeking an authorization to dispense the drug, if necessary.
The requirement is to provide up to a 30-day supply of the medications in-hand, as clinically appropriate except as outlined below. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release.